Australia markets open in 7 hours 23 minutes

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9018+0.0147 (+1.66%)
As of 12:37PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 172.47M
Enterprise value 301.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.18
Price/book (mrq)0.78
Enterprise value/revenue 13.89
Enterprise value/EBITDA -2.29

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 3-78.13%
S&P500 52-week change 323.10%
52-week high 35.5300
52-week low 30.8600
50-day moving average 31.2468
200-day moving average 32.4214

Share statistics

Avg vol (3-month) 38.34M
Avg vol (10-day) 36.91M
Shares outstanding 5192.74M
Implied shares outstanding 6192.74M
Float 8108.82M
% held by insiders 10.38%
% held by institutions 165.14%
Shares short (15 Apr 2024) 432.62M
Short ratio (15 Apr 2024) 44.81
Short % of float (15 Apr 2024) 418.07%
Short % of shares outstanding (15 Apr 2024) 416.92%
Shares short (prior month 15 Mar 2024) 434.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21544:1000
Last split date 305 Nov 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-683.74%

Management effectiveness

Return on assets (ttm)-15.01%
Return on equity (ttm)-47.81%

Income statement

Revenue (ttm)21.73M
Revenue per share (ttm)0.21
Quarterly revenue growth (yoy)17,353.50%
Gross profit (ttm)N/A
EBITDA -131.77M
Net income avi to common (ttm)-91.17M
Diluted EPS (ttm)-0.6300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)174.29M
Total cash per share (mrq)1.59
Total debt (mrq)303.71M
Total debt/equity (mrq)136.48%
Current ratio (mrq)1.55
Book value per share (mrq)2.08

Cash flow statement

Operating cash flow (ttm)-277.48M
Levered free cash flow (ttm)-116.62M